A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression

David J Gregory1, Marianne Godbout, Irazú Contreras

  • 1Centre for the Study of Host Resistance, Research Institute of the McGill University Health Centre, Montréal, Canada.

Insights

Leishmania parasites cleave the NF-kappaB p65 RelA protein in macrophages, creating a fragment that promotes chemokine gene expression. This novel mechanism highlights pathogen manipulation of host immune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • Leishmania parasites are obligate intracellular pathogens residing within macrophage phagolysosomes.
  • Pathogen manipulation of host cell signaling and gene expression is crucial for Leishmania survival and disease.
  • Understanding these interactions is key to developing effective treatments.

Purpose of the Study:

  • To investigate the impact of Leishmania infection on host cell signaling pathways, specifically NF-kappaB.
  • To identify the mechanism by which Leishmania alters NF-kappaB activity.
  • To determine the functional consequences of Leishmania-induced NF-kappaB modification.

Main Methods:

  • In vitro infection of macrophages with Leishmania promastigotes.
  • Analysis of NF-kappaB p65 RelA subunit cleavage using biochemical assays.
  • Identification of the responsible Leishmania protease (gp63).
  • Investigation of nuclear translocation and DNA binding of cleaved NF-kappaB fragments.
  • Assessment of chemokine gene expression induction.

Main Results:

  • Leishmania infection specifically cleaves the NF-kappaB p65 RelA subunit in the cytoplasm.
  • The Leishmania protease gp63 mediates this cleavage, generating a p35 RelA fragment.
  • The p35 RelA fragment translocates to the nucleus and forms functional heterodimers with NF-kappaB p50.
  • These dimers activate transcription of key chemokine genes (MIP-2, MCP-1, MIP-1alpha, MIP-1beta).
  • Cleavage occurs with pathogenic Leishmania species but not non-pathogenic strains or IFN-gamma treatment.

Conclusions:

  • Leishmania employs a novel mechanism to subvert macrophage regulatory pathways by cleaving NF-kappaB p65 RelA.
  • The resulting p35 RelA/p50 complex activates chemokine gene expression, potentially contributing to Leishmania pathogenesis.
  • This study reveals a new strategy used by pathogens to manipulate host immunity for their survival.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...